Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Oil-Dri Corporation Of America Q3 Earnings Call Highlights

Oil-Dri Corporation Of America (NYSE:ODC) reported stronger fiscal third-quarter sales and operating income, while management cautioned that higher costs and an ongoing capital investment cycle are continuing to pressure margins. On the company’s Q3 fiscal 2026 earnings webcast, Chief Financial Off

MarketBeat

The J.M. Smucker Company’s Dividend: Too Sweet to Ignore?

J.M. Smucker Compay is in the midst of a business turnaround that will deliver an attractive total return for income investors over time.

MarketBeat

From Crypto to AI: Insiders Are Trading These 3 Stocks

See the beaten-down and surging stocks that insiders are trading, from one of the biggest names in crypto to an NVIDIA-linked chip company.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

United Natural Foods Q3 Earnings Call Highlights

United Natural Foods (NYSE:UNFI) reported stronger third-quarter fiscal 2026 profitability and cash flow despite lower sales, as management said network optimization, productivity initiatives and supply chain investments continued to reshape the business. On the company’s earnings call, CEO Sandy D

MarketBeat

Amgen Eyes 2026 ‘Springboard’ as Growth Drugs Offset Patent Pressure

Amgen (NASDAQ:AMGN) executives said the company’s first-quarter performance supports its view that 2026 can serve as a “springboard year,” with growth products helping offset increased competition for the denosumab franchise and other losses of exclusivity. Speaking at a Goldman Sachs event, Peter

MarketBeat

Lands' End Q1 Earnings Call Highlights

Lands' End (NASDAQ:LE) reported lower first-quarter revenue as a distribution center systems rollout delayed shipments, but executives said underlying demand improved and described the recently completed joint venture with WHP Global as a major strategic reset for the apparel retailer. Chief Execut

MarketBeat

SailPoint Q1 Earnings Call Highlights

SailPoint (NASDAQ:SAIL) reported a stronger-than-expected start to fiscal 2027, with management pointing to continued SaaS migration activity, larger customer commitments and growing demand for identity security tied to artificial intelligence agents and other non-human identities. On the company’s

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Titan Machinery Q1 Earnings Call Highlights

Titan Machinery (NASDAQ:TITN) reported fiscal first-quarter results that management said were slightly ahead of expectations, helped by earlier-than-anticipated equipment margin improvement, but the company reaffirmed its full-year outlook as demand remains pressured across key customer groups. Pre

MarketBeat

Molten Ventures H2 Earnings Call Highlights

Molten Ventures (LON:GROW) said portfolio fair value growth accelerated during the year, while management pointed to defense, space, artificial intelligence and European technology sovereignty as major structural themes shaping its investment strategy. Chief Executive Ben Wilkinson told investors t

MarketBeat

EHang Q1 Earnings Call Highlights

EHang (NASDAQ:EH) said it remains focused on moving from aircraft certification to commercial operations after reporting first-quarter 2026 revenue that was roughly flat year over year but sharply lower than the prior quarter due to delivery timing and seasonal factors. Founder, Chairman and Chief

MarketBeat

Has Temu-Owner PDD's Story Changed After Double Miss?

Temu owner PDD keeps sinking. The company is prioritizing long-term competitiveness over short-term results, creating potential for an extended recovery.

MarketBeat

TH International Q1 Earnings Call Highlights

TH International (NASDAQ:THCH), the operator of Tims China, reported weaker first-quarter 2026 sales as management continued to close underperforming stores, reduce discount-driven promotions and shift resources toward franchising and profitability. On the company’s earnings call, CEO Director Yong

MarketBeat

Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead

Annexon (NASDAQ:ANNX) executives used a Goldman Sachs Healthcare Conference session to outline the company’s upcoming clinical and regulatory catalysts, led by pivotal Phase III data expected in the fourth quarter for vonaprument in geographic atrophy, a form of advanced dry age-related macular dege

MarketBeat

J. M. Smucker Q4 Earnings Call Highlights

J. M. Smucker (NYSE:SJM) executives said the company is entering fiscal 2027 with momentum across key brands, while cautioning that commodity costs, tariffs and consumer behavior remain important variables in its outlook. During the company’s fiscal fourth-quarter earnings question-and-answer sessi

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Cybersecurity Earnings: 1 AI Standout and 2 Stocks Under Pressure

Volatility was the operative word to describe the latest round of cybersecurity earnings. See who skyrocketed, and who got markets knocked down a peg.

MarketBeat

AirJoule Technologies: A Cool Shot at a Multibagger

AirJoule Technology is on track to comercialize its technology and unleadh a torrent of demand, hyper revenue growth, and a quick path to profits.

MarketBeat

Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears

Caribou Biosciences (NASDAQ:CRBU) Chief Executive Officer Rachel Haurwitz said the company is advancing two CRISPR-enabled, off-the-shelf CAR T cell therapy programs, with its lymphoma candidate vispa-cel now “pivotal-ready” and its multiple myeloma program CB-011 continuing in Phase 1 development.

MarketBeat

Oxford Instruments H2 Earnings Call Highlights

Oxford Instruments (LON:OXIG) said it delivered a stronger second half after a difficult start to the year, as improving demand from commercial semiconductor customers helped offset weaker academic markets and geopolitical uncertainty. Chief Executive Richard Tyson told investors the company was “r

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Corbus Pharmaceuticals Teases Cancer, Obesity Data as Key Clinical Readouts Near

Corbus Pharmaceuticals (NASDAQ:CRBP) Chief Executive Yuval Cohen outlined the company’s near-term clinical readout schedule and development plans for its two lead drug candidates during a Jefferies fireside chat hosted by biotech analyst Amin Makarem. Cohen said the Norwood, Massachusetts-based dru

MarketBeat

Hemab Therapeutics Details Post-IPO Pipeline Push, Sutacimig Phase III Plans

Hemab Therapeutics (NASDAQ:COAG) Chief Executive Officer Benny Sorensen outlined the company’s development plans following its recent initial public offering during a fireside chat with Jefferies biotech analyst Maury Raycroft. Sorensen said Hemab is pursuing a strategy to build “a multiple product

MarketBeat

Zepp Health Q1 Earnings Call Highlights

Zepp Health (NYSE:ZEPP) reported a stronger start to 2026, with management pointing to new Amazfit product launches, a higher-end product mix and expanding positioning in hybrid training as the main drivers of first-quarter growth. On the company’s earnings call, Founder and Chief Executive Officer

MarketBeat

CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans

CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted discussion. Chief Executive Officer John Hanna said CareDx has reshaped its portfolio around areas

MarketBeat

Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls

Bioventus (NASDAQ:BVS) executives outlined the company’s portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering U.S. medtech and healthcare IT. Mark Singleton, Bioventus’ senior vice president and chief financi

MarketBeat

Vail Resorts Q3 Earnings Call Highlights

Vail Resorts (NYSE:MTN) said historically poor weather across the Western United States continued to weigh on fiscal third-quarter results, pressuring visitation and revenue at its mountain resorts while management emphasized that its advance commitment pass model and cost controls helped cushion th

MarketBeat

Gloo Q1 Earnings Call Highlights

Gloo (NASDAQ:GLOO) reported fiscal first-quarter revenue and adjusted EBITDA ahead of its own guidance and Wall Street consensus, as executives pointed to momentum from large strategic customers, recent acquisitions and growing demand for AI-enabled technology and marketing tools across faith-based

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.